Program Committee Share

To download the Program Committee brochure here.

Tony Rook

Tony A. Rook leads the Microbiology Resource Center at The Sherwin-Williams Company in Cleveland, OH, USA, where he has built a world-class Microbiology Center of Excellence to focus on global preservation strategies, continuous improvement of industrial hygiene practices, and ...
See more See less
Philip Geis

Philip A. Geis is a native Texan who earned bachelor and doctor of philosophy degrees in microbiology and mycology from The University of Texas. Between these efforts, he served in the US Army with final duty as clinical microbiologist for the Army's 45th field hospital APO ...
See more See less
Fred Russell Kramer, PhD

Fred Russell Kramer is Professor of Microbiology and Molecular Genetics at the New Jersey Medical School, and has been a Principal Investigator at the Public Health Research Institute for the past 25 years. He graduated from the University of Michigan in 1964 and received his ...
See more See less
Emily Hollister

Emily Hollister is the Director, R&D, Computational Biology for Diversigen. An accomplished microbial ecologist, her microbiome experience ranges from soils and biofuel production systems to the human microbiome and pre-clinical disease models. She leads a team of ...
See more See less

SEP 7 - 8 2016

Microbiology & Immunology Virtual Event Series 2016

The 2nd Annual Event in the Microbiology & Immunology Virtual Event Series is now On Demand! This premier venue discusses the latest research on microscopic organisms and their interaction with the human body. View this conferenceat at no charge, any time.

Watch this video to learn about this exciting conference!

Microbiology & Immunology 2016 features informative presentations from keynote speakers and experts including; Dr. Peter Palese, Dr. Amy Leber, Dr. Marilyn Roossinck, Dr. Dan Diekema, Dr. Matthew Fields, and Dr. Jack Gilbert. Check out the virtual conference to view these and other great speakers at your convenience.

Microbes have been around longer than anything else and are one of the most abundant organisms on Earth. In fact, there are more microbes on one person’s hand than there are people on the planet. Studies of the microbiome have been successful in teaching us more about the roles microbes play in human health and disease. Microbiology & Immunology 2016 highlights new research in this area as well as updates on emerging infection investigations and new technologies used for microbe testing.

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRmicro to follow the conversation

Speakers

Peter Palese, PhD

Professor and Chair Department of Microbiology, Professor in Department of Medicine and Infectious Diseases, Icahn School of Medicine at Mount Sinai
BIOGRAPHY
Amy Leber, PhD

Director, Clinical Microbiology/ Immunoserology Laboratory, Nationwide Children's Hospital
BIOGRAPHY
Marilyn Roossinck, PhD

Professor, Plant Pathology and Environmental Microbiology and Biology, Center for Infectious Disease Dynamics, W229A Millennium Science Complex, Pennsylvania State University
BIOGRAPHY
Daniel J Diekema, PhD

Professor of Internal Medicine and Pathology, University of Iowa
BIOGRAPHY
Matthew Fields, CBE

Professor, Director, Center for Biofilm Engineering Montana State University
BIOGRAPHY
Jack Gilbert, PhD

Faculty Director, The Microbiome Center, Professor, Department of Surgery, The University of Chicago
BIOGRAPHY
Maureen Hanson

Professor, Cornell University
BIOGRAPHY
Roxana Hickey, PhD

Microbial Ecologist and Postdoctoral Scholar, Univeristy of Oregon
BIOGRAPHY
Scott Kelley, PhD

Professor of Biology, San Diego State University
BIOGRAPHY
Paula Revell, PhD

Assistant Professor, Pathology & Immunology, and Pediatrics, Baylor College of Medicine
BIOGRAPHY
Glenn Tillotson, PhD, FIDSA, FCCP

Consultant Medical Microbiologist
BIOGRAPHY
Daniel Turner, PhD

Applications Director, Oxford Nanopore Technologies
BIOGRAPHY
Krishnan Allampallam, PhD

Global Marketing Director, Chembio Diagnostic Systems
BIOGRAPHY
Amy Denison, PhD

Microbiologist, Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
BIOGRAPHY
Clotilde Teiling

Marketing Manager - Microbial Genomics and Infectious Disease Illumina, Inc.
BIOGRAPHY
Wenjie Xu, PhD

Technical Services Scientist, NanoString
BIOGRAPHY
Steven Cagas, PhD

Scientific Affairs Manage, Roche
BIOGRAPHY

Agenda Share

Download Agenda

ondemand

SEP 08, 2016 1:30 PM PDT

The Paradigm Shift in Clinical Microbiology

Steven Cagas, PhD

Scientific Affairs Manage, Roche
BIOGRAPHY

Multi-Drug Resistant Organisms (MDROs) are becoming a bigger and bigger concern throughout the world. Antibiotic resistance forms and spreads faster than pharmaceutical companies have been able to develop new antibiotic compounds. This stagnation in the development of new tools for the clinical laboratory to identify these organisms has equally been a problem. The traditional methods we use to identify and determine antibiotic resistance and susceptibility have not significantly changed for at least 50 years. Although these techniques are effective, they continue to require highly skilled staff, and multiple days to get a definitive result. Novel technologies, like Smarticles, are in development today with the goal to help identify drug resistant organisms the same day that samples are collected with automated systems. Technologies like Smarticles provide the promise of significantly improving our ability to identify carriers of these organisms and prevent them from spreading to other patients in the hospital.
Dr. Cagas will give an overview of the growing threat that MDROs pose, how Clinical Microbiology has evolved to where it is today, and how novel technologies, like Smarticles, have the potential to cause a significant paradigm shift for clinical laboratories and the hospitals they serve.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 12:00 PM PDT

Metagenomics: Influencing Agriculture, Environment and More

Clotilde Teiling

Marketing Manager - Microbial Genomics and Infectious Disease Illumina, Inc.
BIOGRAPHY

This presentation will be demonstrating several different approaches to explore the diversity, function, and ecology of microbial communities. In Metagenomics, the sequencing of DNA directly from a sample without culturing and isolating organisms, has become the principal tool of “meta-omic” analysis.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 12:00 PM PDT

Plant Viruses: Everywhere and Often Mutualistic

Marilyn Roossinck, PhD

Professor, Plant Pathology and Environmental Microbiology and Biology, Center for Infectious Disease Dynamics, W229A Millennium Science Complex, Pennsylvania State University
BIOGRAPHY

Virus Ecology is a field that is gaining momentum, fueled in part by metagenomic studies from many environments previously ignored. Biodiversity studies of plant viruses show that they are abundant in wild plants, most are new to science, and most have persistent life-styles, meaning that they maintain their infection for many generations and lack horizontal transmission. Viruses are often mutualistic in plants, as are the viruses of the fungal endophytes that colonize plants. These relationships are especially important in extreme environments, where viruses can be critical for the survival of plants. New understanding about the complexity of virus-host interactions that involve plants and insects show that viruses can manipulate the activities of insects that are vectors and pollinators. These studies are giving us a new appreciation for the importance of viruses in life on earth.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 10:30 AM PDT

The Serious Science of Schmutz: Deep-sequencing the built environment

Scott Kelley, PhD

Professor of Biology, San Diego State University
BIOGRAPHY

The global trend towards industrialization and urbanization has led to ever more people living and working indoors. Some studies estimate that humans in industrialized countries spend as much as 90% of their lives inside. Thus, for billions of humans the built environment (BE) now represents the modern ecological habitat of Homo sapiens sapiens. In this talk, I will review our groundbreaking studies using molecular tools and bioinformatics to explore BEs such as therapy pools, offices, hospitals and airplanes. I will then discuss our experimental time-series 16S and metagnomic analysis of bacterial and viral community that demonstrated rapid ecological succession and stabilization of communities on restroom surface. Finally, I will describe the SourceTracker program, inspired by our BE studies, which determines how many different communities have contributed to contaminated environment.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 9:00 AM PDT

Keynote Speaker: The Gut Microbiome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, A Neuroimmune Disease

Maureen Hanson

Professor, Cornell University
BIOGRAPHY

ME/CFS is a debilitating disease with a controversial history and multiple names. The Institute of Medicine recently recommended renaming the disease “Systemic Exertion Intolerance Disease (SEID),” based on its hallmark symptom, an inability to increase physical and mental activity beyond a steady-state level without negative consequences. Patients report a profound lack of energy, not an ordinary type of fatigue. Characteristics of the disease will be reviewed along with current information regarding diagnostic criteria.

Many ME/CFS/SEID patients report gastrointestinal as well as inflammatory symptoms. Because the gut microbiome has been observed to be abnormal in inflammatory and metabolic diseases, we examined the bacterial microbiome and blood markers of microbial translocation in a cohort of patients and controls. This presentation will describe our findings and their relevance to the current view of the disease and its underlying pathophysiology.

Learning objective 1: Understand the current diagnostic and clinical criteria for ME/CFS/SEID

Learning objective 2: Understand why levels of lipopolysaccharide and certain proteins are thought to be related to bacterial translocation and inflammation

Learning objective 3: Learn how the gut microbiomes of ME/CFS/SEID patients differ from those of healthy controls

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 7:30 AM PDT

Gene Expression Profiling During Infection NanoString® nCounter accurately quantifies pathogen and host transcripts from tiny amount of infection tissue

Wenjie Xu, PhD

Technical Services Scientist, NanoString
BIOGRAPHY

Our speaker, Wenjie Xu, Ph.D., will present his publication data demonstrating how nCounter® technology can advance your infectious disease research faster and more accurately with unprecedented sensitivity, reproducibility and ease of use. nCounter has been successfully used for identification and profiling of viruses, bacteria and fungi from real life infection samples. One single RNA isolation can generate paired data for both pathogen and host. Thanks to the automated and streamlined workflow, it takes less than 48 hours from sample collection to publication grade figures.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 7:30 AM PDT

The Molecular Pathology Perspective of the CDC's Infectious Diseases Pathology Branch

Amy Denison, PhD

Microbiologist, Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
BIOGRAPHY

The Infectious Diseases Pathology Branch of the Centers for Disease Control and Prevention (CDC) routinely receives autopsy and biopsy tissues for diagnostic evaluation. These tissues are typically formalin-fixed, paraffin-embedded (FFPE) in nature. Initially, histological stains are employed to determine which tissues are affected and the nature of the infectious process. Along with any provided clinical information, this information is then used by the pathologist to request testing for specific pathogens, either by use of immunohistochemical or molecular techniques. As one of the molecular pathologists, my primary tools are PCR and RT-PCR assays specific to bacterial or viral agents. After agarose gel analysis of the amplicons, followed by band excision and purification, Sanger sequencing can be performed using the GenomeLab GeXP™ Genetic Analysis System. Sequences are then trimmed, contigs are created, and consensus sequences are analyzed using the Basic Local Alignment Search Tool (BLAST). Depending on the level of identity reported by the BLAST, specific diagnoses can then be made, providing clinicians, patients, and/or patient’s families with valuable insight. While the process sounds simple and straightforward, there are actually many difficulties that arise when working with FFPE tissues. However, FFPE tissues provide a convenient means to examine tissues for infectious organisms from a variety of geographical locations using multiple modalities with no biosafety risk.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 08, 2016 6:00 AM PDT

Microbial pathogenesis and host immune response

Krishnan Allampallam, PhD

Global Marketing Director, Chembio Diagnostic Systems
BIOGRAPHY

The research community has begun correlating the makeup of individual microbiomes with disorders and diseases such as obesity, atherosclerosis and cancer. To accomplish this, researchers must first identify and characterize these microbial communities and understand the complex immune interactions between host and pathogen. This webinar provides you with a complete overview of the microbiome, metagenomics and host-pathogen interactions. Experimental strategies, from sample to insight, which can facilitate your microbiology and immunology research, are highlighted.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 1:30 PM PDT

Biofilm Diversity and Ecology

Matthew Fields, CBE

Professor, Director, Center for Biofilm Engineering Montana State University
BIOGRAPHY

It is well accepted that microorganisms can exist as self-organized communities attached to surfaces and one another (i.e., biofilm), often surrounded by extracellular polymeric substances (EPS). Microbial biofilms survive and thrive in most environments that contain liquid-solid, liquid-gas, and/or solid-solid interfaces with a multitude of physicochemical conditions. In addition, the biofilms have unique physiology and ecology that contribute to increased survival and growth (e.g., resistance to antimicrobials, heavy metal exposure, desiccation, and substrate-utilization). The uniqueness of microbial biofilms can have both advantageous and deleterious effects on the system of interest and can significantly impact the cycling of C, N, S, and P. Despite decades of research, there is much to learn about the complexity of biofilm communities and their environmental and evolutionary success. In this presentation, the diversity of biofilms will be discussed with examples from different environments, as well as respective microbial composition and function.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 1:30 PM PDT

Manipulating the Microbiome to Prevent and Treat Infection

Daniel J Diekema, PhD

Professor of Internal Medicine and Pathology, University of Iowa
BIOGRAPHY

Healthcare associated infections can be a consequence of a microbiome alteration. Increasingly, treatment and prevention strategies focus on manipulating host microbiota, the two most common examples being (1) suppression of certain skin and mucosal microbiota, and (2) preservation or restoration of intestinal microbial communities.

After this presentation, participants should be able to:

(a) discuss the evidence in support of chlorhexidine application to the skin and oropharynx of hospitalized patients to prevent infection
(b) implement interventions to reduce the likelihood of Clostridium difficile recurrence after host exposure to antimicrobial agents.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 12:00 PM PDT

Community Acquired Bacterial Pneumonia- a 2016 perspective

Glenn Tillotson, PhD, FIDSA, FCCP

Consultant Medical Microbiologist
BIOGRAPHY

Community acquired pneumonia affects over 5 million Americans and 6 million Europeans annually. Typically 5-10% will be admitted to hospital. It is a condition that more often affects the elderly with a commensurately higher mortality rate, which can be as high as 25%. Indeed over 50,000 deaths occur in the USA each year due to this infection. Diagnosis of pneumonia is almost exclusively clinical in terms of signs and symptoms although a positive chest X ray is vital.

Approximately half of all pneumonia infections are caused by bacteria, the remainder are viral in origin. Streptococcus pneumoniae accounts for the majority of the bacterial cases. As with many other bacterial species the pneumococcus is becoming resistant to many of the commonly used antibiotics. As a result the US FDA has re-assigned the infection to be called Community Acquired Bacterial Pneumonia (CABP).

Learned guidelines recommend either a macrolide or a doxycycline as the first choices for the low risk patient or a respiratory fluoroquinolone for those at higher risk or who have failed an initial course. Resistance to both first line agents is increasing in the USA leading to a growing list of adverse consequences such as emergency room visits, hospitalization or re-admission to hospital. This presentation will review the current knowledge of the disease and the challenges of managing these patients.

Learning Objective 1 : to appreciate the escalating burden of CABP in the USA

Learning Objective 2 : to understand the impact antibiotic resistance can have in CABP

Learning Objective 3 : to understand the current challenges in managing CABP

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 10:30 AM PDT

Diagnostic Development and Laboratory Response to Infectious Disease Outbreaks

Paula Revell, PhD

Assistant Professor, Pathology & Immunology, and Pediatrics, Baylor College of Medicine
BIOGRAPHY

The field of infectious disease diagnostics is ever changing with both newly identified infections such as SARS, Ebola, and Zika virus as well as yearly epidemics and potential for pandemic with pathogens that constantly circulate among us such as Influenza. The ability of the laboratory to quickly respond to outbreak situations is critical. This talk will provide an overview of the processes involved in developing, validating and implementing new diagnostic tests in the time sensitive setting of infectious disease outbreaks.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 10:30 AM PDT

Exploring the Great Indoors: Relevance of the Built Environment to Human Health

Roxana Hickey, PhD

Microbial Ecologist and Postdoctoral Scholar, Univeristy of Oregon
BIOGRAPHY

The human body is populated with trillions of microorganisms, collectively termed the human microbiome, that play vital roles in health including nutrition and metabolism, immune development, and protection against pathogens. Likewise, the homes and buildings we inhabit, or the built environment, possess their own microbiomes as well. A growing body of evidence indicates that people, pets, plants, and ventilation and plumbing systems all contribute distinctive suites of microbes indoors, in addition to environmental microbes introduced from outside. Given that humans spend the vast majority of their lives inside, there is a pressing need to understand how the built environment microbiome in turn influences the human microbiome so that we can design buildings that promote and sustain health. In this presentation I will highlight the ways in which humans alter the composition of the indoor environment and what the consequences may be for human health.

Learning Objective 1: Understand the significance of the indoor microbiome to human health
Learning Objective 2: Discuss evidence for how occupancy and operation of buildings can influence the indoor microbiome

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 9:00 AM PDT

Keynote Speaker: You Want Me to Culture What? : Challenging Requests for Culture in the Clinical Microbiology Lab

Amy Leber, PhD

Director, Clinical Microbiology/ Immunoserology Laboratory, Nationwide Children's Hospital
BIOGRAPHY

In an era of healthcare reform and evidenced-based medicine, it is important to use the most clinically relevant and cost effective methods in all aspects of microbiology. This session will cover issues related to culture of challenging clinical and non-clinical specimens including objects, fluids and environmental samples. While there is some consensus about the more routine aspects of clinical testing, much less information is available about the topics covered in this symposium. The culturing of unusual objects are areas where laboratorians are often faced with the dilemma if, or to what extent, cultures should be worked up. The goal is to provide information to support medically relevant, regulatory-compliant, and fiscally prudent processes.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 7:30 AM PDT

Keynote Speaker: Challenges towards a Universal Influenza Virus Vaccine

Peter Palese, PhD

Professor and Chair Department of Microbiology, Professor in Department of Medicine and Infectious Diseases, Icahn School of Medicine at Mount Sinai
BIOGRAPHY

Despite FDA-approved vaccines and antivirals, seasonal and pandemic influenza remains a serious threat associated with substantial morbidity and mortality. The present modalities and vaccine approaches will be discussed and the difficulties one faces with the presently available formulations will be addressed. While annual seasonal influenza virus vaccination is frequently effective – albeit underutilized in most countries – a safe universal influenza virus vaccine providing broad and long-lasting immunity would represent a major breakthrough. We have developed vaccine constructs which express chimeric hemagglutinins resulting in the redirection of the immune response away from the immunodominant (variant) head domain of the hemagglutinin toward the much more conserved stalk of the hemagglutinin and the highly conserved neuraminidase. Such vaccine constructs work well in animal challenge models and await extensive clinical trials in humans.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 6:00 AM PDT

Invisible Influence: How the indoor microbiome influences health

Jack Gilbert, PhD

Faculty Director, The Microbiome Center, Professor, Department of Surgery, The University of Chicago
BIOGRAPHY

The human race, like all macrobiological life, evolved in a sea of microbes. There was no way to keep the bacterial and archaeal hoards at bay, so instead life evolved mechanisms to live with these invaders. The immune system was refined over millions of years to control our interaction with the microbial world, and even to use it as a mechanism of defense, food processing, and vitamin production. The immune system and the microbiome have shaped each other in extraordinarily elaborate and intricate ways. Here we will discuss some of the recent evidence highlighting these mechanisms of interaction. We will also discuss how the last 150 years, have started to disturb the delicate balance of the immune-microbe equilibrium. As our natural ecosystem has been restricted to the built environment, especially in the developed world, where an average of 90% of our lives take place indoors, our exposure to the microbial world has been corrupted. Modern buildings are equipped with surfaces and environmental systems designed to reduce the potential for microbial life to flourish. This fundamental shift in our lifestyle is likely impacting the development and function of our immune systems in ways that we are only beginning to understand. We are now starting to experiment with adding bacteria back in to our overly sterile existence, in one such study we were able to significantly reduce cows milk allergy in infants through active manipulation of the gastrointestinal microbiota. Exploring the dynamic interactions that humans share with our indoor space, and mapping the interactions that lead to alterations in our own microbiome will be extremely important for determining the best way to augment our environment with a beneficial microbiome.

Learning Objective 1: To understand the concept of the microbiome and it's importance in human health

Learning Objective 2: To be able to identify routes of transmission of the microbiome to a human host.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar
SEP 07, 2016 6:00 AM PDT

MinION™ Applications: Microbial genomics and direct RNA sequencing

Daniel Turner, PhD

Applications Director, Oxford Nanopore Technologies
BIOGRAPHY

Oxford Nanopore’s MinION is a small sensing device which can sequence DNA and RNA directly, without the need to perform an enzymatic synthesis reaction. The device is portable and is powered by USB. Oxford Nanopore’s workflows are capable of performing real-time biological analyses.

In this presentation we give a brief introduction to the technology, and describe the work performed by Oxford Nanopore’s Applications team on the use of the MinION for direct RNA sequencing and for analysis of microbial genomes and communities.

SEE ABSTRACT HIDE ABSTRACT

Watch Webinar

Speakers Share

Peter Palese, PhD

Professor and Chair Department of Microbiology, Professor in Department of Medicine and Infectious Diseases, Icahn School of Medicine at Mount Sinai

BIOGRAPHY
Amy Leber, PhD

Director, Clinical Microbiology/ Immunoserology Laboratory, Nationwide Children's Hospital

BIOGRAPHY
Marilyn Roossinck, PhD

Professor, Plant Pathology and Environmental Microbiology and Biology, Center for Infectious Disease Dynamics, W229A Millennium Science Complex, Pennsylvania State University

BIOGRAPHY
Daniel J Diekema, PhD

Professor of Internal Medicine and Pathology, University of Iowa

BIOGRAPHY
Matthew Fields, CBE

Professor, Director, Center for Biofilm Engineering Montana State University

BIOGRAPHY
Jack Gilbert, PhD

Faculty Director, The Microbiome Center, Professor, Department of Surgery, The University of Chicago

BIOGRAPHY
Maureen Hanson

Professor, Cornell University

BIOGRAPHY
Roxana Hickey, PhD

Microbial Ecologist and Postdoctoral Scholar, Univeristy of Oregon

BIOGRAPHY
Scott Kelley, PhD

Professor of Biology, San Diego State University

BIOGRAPHY
Paula Revell, PhD

Assistant Professor, Pathology & Immunology, and Pediatrics, Baylor College of Medicine

BIOGRAPHY
Glenn Tillotson, PhD, FIDSA, FCCP

Consultant Medical Microbiologist

BIOGRAPHY
Daniel Turner, PhD

Applications Director, Oxford Nanopore Technologies

BIOGRAPHY
Krishnan Allampallam, PhD

Global Marketing Director, Chembio Diagnostic Systems

BIOGRAPHY
Amy Denison, PhD

Microbiologist, Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.

BIOGRAPHY
Clotilde Teiling

Marketing Manager - Microbial Genomics and Infectious Disease Illumina, Inc.

BIOGRAPHY
Wenjie Xu, PhD

Technical Services Scientist, NanoString

BIOGRAPHY
Steven Cagas, PhD

Scientific Affairs Manage, Roche

BIOGRAPHY

Sponsors & Partners Share

For information on becoming a sponsor or exhibitor, please click here.

Roche Diagnostics

Roche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives. Currently, Roche Diagnostics leads the ...
See more See less
Illumina

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems dedicated to making genomics useful for all. Innovating at the intersection of technology, biology, and health, we are reimagining what's possible for human health and the ...
See more See less
ATCC

ATCC is the premier global biological materials resource and standards organization whose mission focuses on the acquisition, authentication, production, preservation, development, and distribution of standard reference microorganisms, cell lines, and other materials. While ...
See more See less
NanoString Technologies

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications ...
See more See less
Sciex

Placing the power of life-changing answers into the hands of those who care, everywhere.
QIAGEN

QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life - DNA, RNA and proteins. We deliver Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights. This is ...
See more See less
Oxford Nanopore Technologies

Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education ...
See more See less
Immunochemistry Technologies

ImmunoChemistry Technologies, LLC provides quality laboratory services and research reagents. As a contract service laboratory, ICT specializes in custom immunoassay development, manufacturing, conjugation, lyophilization, and consulting services. ICT is focused on ELISA ...
See more See less
Beckman Coulter Lumigen

Lumigen, a Beckman Coulter company, is one of the world's largest suppliers of chemiluminescent reagents to the clinical immunodiagnostics market. Lumigen is continually at the forefront of the development of innovative new detection technologies for the clinical laboratory and ...
See more See less
MBL International

MBL International Corporation is a leading life science company focused on providing high-quality products and solutions for life science research and clinical diagnostics. Established in 1993 as a subsidiary of Medical and Biological Laboratories Co. Ltd, Nagoya, Japan, MBL ...
See more See less
Miltenyi Biotec

For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...
See more See less
Garland Science

Garland Science is a leading textbook publisher in the life sciences, particularly in the fields of cell and molecular biology, immunology, genetics and protein science. Our exceptional authors, who are highly respected leaders in their fields, make the science accessible to ...
See more See less
MediMabs

MédiMabs' mission is to be the "Go To" supplier, sought by biomedical researchers seeking quality antibodies and services that are required for the rapidly evolving, complex applications of their projects, generated in a profitable, regulated laboratory and supported by ...
See more See less
Bosterbio

Boster is an antibody manufacturer founded in 1993 by famed histologist, Steven Xia. Over the past two decades, Boster's products have been cited in over 12,000 publications. We specialize in developing ELISA kits and antibodies with high affinity and at affordable prices. One ...
See more See less
Taylor & Francis

aylor & Francis partners with world-class authors, from leading scientists and researchers, to scholars and professionals operating at the top of their fields. Together, we publish in all areas of the Humanities, Social Sciences, Behavioural Sciences, Science, Technology and ...
See more See less
Advanced Instruments

Advanced Instruments, Inc., is headquartered in Norwood, Massachusetts. Founded in 1955, the company is the world's foremost authority for the application of Freezing Point Depression technology for measuring the osmolality of solutions. Since the company's inception ...
See more See less
Alpha Biosciences

Alpha Biosciences is a U.S. company based in Baltimore, Maryland that specializes in the manufacturing of classic and custom culture media for microbiological and molecular biology applications. While many offer culture media as one of a host of products, at Alpha culture media ...
See more See less
Inova Diagnostics
American Biological Safety Association

The American Biological Safety Association (ABSA) was founded in 1984 to promote biosafety as a scientific discipline and serve the growing needs of biosafety professionals throughout the world. The Association's goals are to provide a professional association that represents the ...
See more See less
Research Square

Founded in 2004, Research Square provides innovative solutions to help researchers successfully communicate their work. These solutions include author and manuscript services from AJE American Journal Experts as well publisher solutions such as peer review, independent ...
See more See less
Wako Chemicals USA, Inc.

Since the establishment of our first satellite sales office in Dallas, TX (1981), to the construction of our corporate headquarters and manufacturing facilities in Richmond, VA (1989), Wako Chemicals USA has strived to provide customers in all scientific disciplines with products ...
See more See less
Qlucore

Qlucore began as a collaborative research project at Lund University, Sweden, with researchers in the Departments of Mathematics and Clinical Genetics. From the beginning, the main problem the project faced was the vast amount of high-dimensional data generated by microarray ...
bioMérieux Inc

bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Labroots

Labroots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities.
Biocompare

Biocompare (www.biocompare.com) is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer ...
See more See less
ManuscriptEdit

Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...
See more See less
Pittcon

Pittcon is the worlds largest annual premier conference and exposition on laboratory science. It is organized by The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania not-for-profit educational corporation which is comprised of the ...
See more See less